Thomas Reiser: How Can Medical and Healthcare Associations Stay Impactful in a Changing Environment?
Thomas Reiser, Former Executive Director at the International Society on Thrombosis and Haemostasis, reposted from ESAE on LinkedIn adding:
”What are the strategies that will keep medical-scientific and healthcare associations impactful and successful in an ever shifting environment full of challenges and opportunities?
I very much look forward to discussing what it will take to prepare for what lies ahead and stay relevant with my talented co-panelists at the upcoming ESAE – European Society of Association Executives Association Summit on March 26 in Brussels.
If you are leading a medical-professional or healthcare organization you don’t want to miss this session!”
Quoting European Society of Association Executives (ESAE)‘s post:
”Will Health Associations still be around in 20 years?
Demographics are shifting.
The shortage of health professionals is growing. Fewer young people are choosing medical careers.
What does this mean for membership-based medical societies? For congress participation?
For volunteer engagement? For long-term societal impact?
At EAS26, ESAE’s Health Community is bringing this urgent conversation to the stage in an interactive session that will explore how Health Associations can prepare for what lies ahead, from revenue diversification and congress strategy to sponsorship models and policy influence.
We are pleased to welcome as speakers:
- Davi Kaur, CEO, European Society for Emergency Medicine
- Frédéric Destrebecq, Executive Director, European Brain Foundation
- Alessandro Jacques Cortese, CEO, European Society for Radiotherapy and Oncology (ESTRO)
- Thomas Reiser, Industry Expert
If you work in the health Association space, this is not a conversation to miss at the European Association Summit!
You haven’t secured your EAS26 ticket yet?
Now it’s the time.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:23Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants